Enviva Inc.
EVA · NYSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $4 | $4 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $1 | $1 |
| Enterprise Value | $2 | $5 | $5 | $3 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 10.1% | 5% | 19% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -13.2% | 15.2% | 7.5% | 12.2% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -28% | 1.7% | -1.3% | 2.5% |
| Net Income | -$1 | -$0 | -$0 | $0 |
| % Margin | -57% | -15.4% | -13.9% | 2% |
| EPS Diluted | -9.23 | -2.51 | -2.77 | 0.33 |
| % Growth | -267.7% | 9.4% | -939.4% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |